Prime Medicine (PRME) Total Current Liabilities: 2021-2025
Historic Total Current Liabilities for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to $35.0 million.
- Prime Medicine's Total Current Liabilities fell 7.55% to $35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year decrease of 7.55%. This contributed to the annual value of $38.0 million for FY2024, which is 32.72% down from last year.
- As of Q3 2025, Prime Medicine's Total Current Liabilities stood at $35.0 million, which was up 2.67% from $34.1 million recorded in Q2 2025.
- Prime Medicine's 5-year Total Current Liabilities high stood at $58.0 million for Q4 2021, and its period low was $20.7 million during Q2 2024.
- Its 3-year average for Total Current Liabilities is $33.9 million, with a median of $34.3 million in 2025.
- Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 53.93% in 2022, then spiked by 111.21% in 2023.
- Quarterly analysis of 5 years shows Prime Medicine's Total Current Liabilities stood at $58.0 million in 2021, then tumbled by 53.93% to $26.7 million in 2022, then surged by 111.21% to $56.4 million in 2023, then crashed by 32.72% to $38.0 million in 2024, then decreased by 7.55% to $35.0 million in 2025.
- Its Total Current Liabilities was $35.0 million in Q3 2025, compared to $34.1 million in Q2 2025 and $34.3 million in Q1 2025.